Two optimal prefilter cutoff frequencies needed for SPECT images of myocardial perfusion in a one-day protocol.

OBJECTIVE The purpose of this study was to determine if cutoff frequencies of two-dimensional Butterworth filters need to be changed, depending upon the amount of radiopharmaceutical administered in one-day protocols for reconstructing SPECT images of myocardial perfusion. METHODS A scintilation camera and a phantom were used with 2.2 MBq and 10.6 MBq 99mTc. These activities corresponded to the approximate amounts used in our one-day myocardial perfusion imaging protocol. The projection data were collected in 30 positions spread over 180 degrees. Thirty- and 150-sec acquisitions per position were performed to obtain the study and the high-quality reference images. Thirteen cutoff frequencies of the filter were used to reconstruct the SPECT images. Optimal cutoff frequencies were determined by visual assessment and by calculating the normalized mean square error (n.m.s.e). These results were then compared. The same protocol was used to image three volunteers with no heart disease and the images were evaluated visually. RESULTS In the phantom study, the optimal cutoff frequencies were 0.225 cycles/pixel for 2.2 MBq, and 0.275 cycles/pixel and 0.25 cycles/pixel for 10.6 MBq by visual inspection, and were 0.225 cycles/pixel and 0.275 cycles/pixel by calculating the n.m.s.e., respectively. In the patient study, the lower cutoff frequency of 0.20 cycles/pixel was optimal for the exercise study (low dose), while the higher cutoff frequencies of 0.275 cycles/pixel was optimal for the resting study (high dose). CONCLUSION The optimal cutoff frequencies differed for the two activity levels. Cutoff frequencies should be changed according to the amounts of radiopharmaceuticals used for the first and the second examinations in one-day protocols.

[1]  R. Itti,et al.  Myocardial imaging with technetium-99m-tetrofosmin: comparison of one-day and two-day protocols. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  R H Jones,et al.  Perfusion and function at rest and treadmill exercise using technetium-99m-sestamibi: comparison of one- and two-day protocols in normal volunteers. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  D. Berman,et al.  Comparison of technetium 99m methoxy isobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods. , 1989, American heart journal.

[4]  J M Links,et al.  Wiener filtering improves quantification of regional myocardial perfusion with thallium-201 SPECT. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  E G DePuey,et al.  Technical aspects of myocardial SPECT imaging with technetium-99m sestamibi. , 1990, The American journal of cardiology.

[6]  Y. Yonekura,et al.  Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  P W Doherty,et al.  Constrained least-squares restoration of nuclear medicine images: selecting the coarseness function. , 1987, Medical physics.

[8]  F. Smith,et al.  Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  J. Mattera,et al.  Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  D. Berman,et al.  Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  J. Heo,et al.  Comparison of same-day protocols using technetium-99m-sestamibi myocardial imaging. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  C. Boucher,et al.  Myocardial perfusion studies: lessons from a decade of clinical use. , 1986, Radiology.

[13]  M T Madsen,et al.  Spatial resolution and count density requirements in brain SPECT imaging. , 1992, Physics in medicine and biology.

[14]  J. Maublant,et al.  Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  R. Itti,et al.  Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease. , 1993, The American journal of cardiology.

[16]  T R Miller,et al.  Fast count-dependent digital filtering of nuclear medicine images: concise communication. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.